Copyright
©The Author(s) 2020.
World J Stem Cells. Jan 26, 2020; 12(1): 87-99
Published online Jan 26, 2020. doi: 10.4252/wjsc.v12.i1.87
Published online Jan 26, 2020. doi: 10.4252/wjsc.v12.i1.87
Figure 7 Effect of HIF-2α on the PI3K/AKT signaling pathway.
In MDA-MB-231 cells induced by hypoxia, HIF-2α knockdown reduced the AKT and mTOR phosphorylation levels; aP < 0.05 vs normoxia; bP < 0.05 vs hypoxia + NC. PI3K: Phosphoinosmde-3-kinase; AKT: Protein-serine-threonine kinase; mTOR: Mammalian target of rapamycin; p-AKT: Phosphorylated AKT; p-mTOR: Phosphorylated mTOR; NC: Negative-sequence control.
- Citation: Bai J, Chen WB, Zhang XY, Kang XN, Jin LJ, Zhang H, Wang ZY. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling. World J Stem Cells 2020; 12(1): 87-99
- URL: https://www.wjgnet.com/1948-0210/full/v12/i1/87.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i1.87